Dopamine Agents: all 740 studies that test it

Page 5 of 8. Open to participants first (58), then studies with results posted, then the rest; newest registration first within each.

• Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal CancerActive, not recruitingNCT04137107Phase 2/3
• Duloxetine Combined With Intra-articular Injection of Corticosteroid and Hyaluronic Acid Reduces Pain in the Treatment of Knee Osteoarthritis PatientsCompletedNCT04117893Phase 4
• Exercise Plus Duloxetine for Knee OsteoarthritisCompletedNCT04111627Phase 2
• Transition From Acute to Chronic Back Pain : Effect of L-dopa,Gender,and Associated Brain PlasticityWithdrawnNCT04082715Phase 2
• Acute Effects of Pharmacological Neuromodulation on Leg Motor Activity in Patients With SCI Treated With EESCompletedNCT04052776Phase 1
• Amphetamine Extended Release Tablets and Driving Performance in Subjects With Attention Deficit/Hyperactivity Disorder (ADHD)CompletedNCT04027361Phase 2
• Effects of 5HTP and LDOPA on CNS Excitability After SCISuspendedNCT04000919Phase 2/3
• Evaluation of the Effect of Preoperative Intravenous Amantadine Sulfate on the Postoperative Early Cognitive Functions in a Elderly Patient With Laparoscopic Radical ProstatectomyStatus unknownNCT03988010Phase 4
• Oxytocin and Dopamine's Effect on Vicarious OptimismCompletedNCT03891095Not applicable
• Pharmacokinetic Study of CVT-301 (Levodopa Inhalation Powder)CompletedNCT03887884Phase 1
• Effects of Duloxetine on Postoperative Wound Complication of Total Knee Arthroplasty (TKA) in Central Sensitization PatientsStatus unknownNCT03880916Not applicable
• Inhibition of α-synuclein Cell-cell Transmission by NMDAR Blocker, MemantineStatus unknownNCT03858270Phase 3
• A Study Of Duloxetine Hydrochloride Hard Gelatinous Capsule Compared To Cymbalta Under Fed ConditionsWithdrawnNCT03794154Phase 4
• Pre-emptive Effect of Duloxetine in the Second Knee in Staged Total Knee ArthroplastyStatus unknownNCT03792828Phase 4
• Dopamine and Norepinephrine Infusion With Restricted HydrationCompletedNCT03780686Not applicable
• Memantine for Epileptic EncephalopathyCompletedNCT03779672Phase 4
• Pharmacological Modulation of Belief SalienceCompletedNCT03754062Phase 1
• A Study of Duloxetine Hydrochloride Hard Gelatinous Capsule Compared To CymbaltaWithdrawnNCT03729284Phase 4
• Add-on Low Dose Dextromethorphan and Memantine in Patients With Amphetamine-type Stimulants Use DisorderCompletedNCT03729128Phase 1/2
• Memantine and Post-mastectomy Neuropathic PainStatus unknownNCT03686774Phase 2
• Study in Healthy Subjects to Compare Two Tablet Formulations of Memantine (Ebixa®) in Fasted and Fed ConditionsCompletedNCT03670095Phase 1
• A Prediction Study of Multiple Indexes of the Effect of Different Mechanisms of Antidepressants Treatment on DepressionStatus unknownNCT03623711Early Phase 1
• Duloxetine Role in Reducing Opioid Consumption After ThoracotomyCompletedNCT03618225Phase 4
• Oral Amantadine, IV Amantadine and Hemodynamic Response to LaryngoscopyStatus unknownNCT03612921Phase 2
• Duloxetine Potentiates the Analgesic Efficacy of Intrathecal MorphineCompletedNCT03560427Not applicable
• Memantine for the Treatment of Social Deficits in Youth With Disorders of Impaired Social InteractionsTerminatedNCT03553875Phase 3
• Analgesic Efficacy of Duloxetine in Patients Undergoing Lumbar DiscectomyStatus unknownNCT03549026Not applicable
• Memantine for the Treatment of Cognitive Impairment in Systemic Lupus ErythematosusCompletedNCT03527472Phase 2
• Effects of Amantadine on Postoperative Cognitive DysfunctionStatus unknownNCT03527134Not applicable
• Duloxetine for Acute Post-mastectomy PainCompletedNCT03468348Not applicable
• Citicholine-Amantadine Trial in Traumatic Brain InjuryCompletedNCT03430817Phase 4
• Perioperative Duloxetine for Pain Management After Laparoscopic HysterectomyCompletedNCT03350334Not applicable
• Effect of Memantine on Radiotherapy-related Cognitive ImpairmentStatus unknownNCT03342443Phase 2/3
• Exceptional Experiences (EE), Salience & Dopaminergic NeurotransmissionCompletedNCT03333369Early Phase 1
• 'Fix the Dysfunction' Concept for Mechanism-based Pharmacological Treatment of Neuropathic Pain by DrugCompletedNCT03276689Not applicable
• Histaminergic Basis of Central Fatigue in Multiple Sclerosis - A Novel ApproachCompletedNCT03266965Phase 1
• Duloxetine for Post Laparoscopic Shoulder PainCompletedNCT03249168Phase 3
• A Phase - IIa - IIb, Trial to Study the Safety, Tolerability and Efficacy of Memantine as a Long-term Treatment of SCDStatus unknownNCT03247218Phase 2
• Clinical Trial of Levodopa/Carbidopa ( Sinemet) Therapy in Angel Man SyndromeCompletedNCT03235037Not applicable
• Measuring Parkinson's Disease ProgressionCompletedNCT03205956Phase 1
• Effects of Dexmedetomidine and Dopamine on Renal Function After Major SurgeryStatus unknownNCT03170739Phase 4
• Memantine Treatment in Alzheimer's Disease PatientsStatus unknownNCT03168997Phase 4
• A Diagnosis and Treatment Optimization Study of Depression Based on the Neurological Mechanism of Reward SystemStatus unknownNCT03148522Not applicable
• Efficacy and Safety of Duloxetine Among Individuals With Depressive Disorder in a 12 Weeks TrialCompletedNCT03121573Not applicable
• Safety and Efficacy Study of Human ESC-derived Neural Precursor Cells in the Treatment of Parkinson's DiseaseStatus unknownNCT03119636Phase 1/2
• Short-term Efficacy of Antidepressant in Patients Underwent TKAStatus unknownNCT03110172Phase 1/2
• The Effect of Norepinephrine Versus Dopamine in Renal Transplant Recipients on Postoperative Graft FunctionStatus unknownNCT03107858Phase 2/3
• Study of Pomaglumetad and MethamphetamineTerminatedNCT03106571Phase 1
• Effect of BIA 6-512 at Steady-state on the Levodopa Pharmacokinetics With a Single-dose of Levodopa/Benserazide 200/50 mg or With a Single-dose of Levodopa/Benserazide 200/50 mg Plus a Single-dose of Nebicapone 150 mgCompletedNCT03097211Phase 1
• Neurobiology of Treatment Responses in MDDWithdrawnNCT03068247Phase 3
• Impact of Genetic Polymorphism on Drug-Drug Interactions Involving CYP2D6CompletedNCT03054220Not applicable
• Memantine in Bipolar Patients With AlcoholismStatus unknownNCT03043001Phase 3
• Combination of Dextromethorphan and Memantine in Treating Bipolar DisorderStatus unknownNCT03039842Phase 3
• Duloxetine for Succinylcholine-induced Postoperative MyalgiaCompletedNCT03037073Phase 2/3
• Role of Dopamine, Serotonin and 5-HT2A Receptors in Emotion ProcessingCompletedNCT03019822Early Phase 1
• The Effect of Dopamine on Pulmonary Diffusion and Capillary Blood Volume During ExerciseCompletedNCT02965963Not applicable
• Treatment Outcome in Major Depressive DisorderCompletedNCT02869035Phase 1
• A Multidisciplinary Approach to Manage Gait Difficulty in Parkinson PatientsWithdrawnNCT02857244Phase 2
• Determination of the Antidepressant Duloxetine in Plasma to Improve the Knowledge of the Analgesic Action of Antidepressants on Chronic Neuropathic PainCompletedNCT02846701Phase 4
• Studying a Potential Protective Effect of L-Dopa on Retinitis PigmentosaStatus unknownNCT02837640Phase 2
• A Study to Compare Two Dose Strengths of CVT-301 (Levodopa Inhalation Powder) With an Oral Dose of Sinemet® (Carbidopa-levodopa) TabletsCompletedNCT02812394Phase 1
• Predicting Treatment Response to Memantine in Autism Using Magnetic Resonance SpectroscopyCompletedNCT02811627Early Phase 1
• A Study of the Safety and Tolerability of a Single Dose Administration of CVT-301 (Levodopa Inhalation Powder)CompletedNCT02807675Phase 1
• Pharmacokinetic-pharmacodynamic Interaction Between BIA 3-202 and Levodopa/BenserazideCompletedNCT02778594Phase 1
• Methylphenidate-Duloxetine Combinations for Cocaine DependenceCompletedNCT02700711Phase 1
• Shifting Pain Modulation From Pro-to Anti-nociceptiveTerminatedNCT02672202Not applicable
• Efficacy Phase IIa Study of CVXL-0107 in Advanced Parkinson's DiseaseCompletedNCT02641054Phase 2
• A Study of the Safety and Levodopa Pharmacokinetics Following Single Dose Administration of CVT 301 (Levodopa Inhalation Powder) in Smoking and Non-Smoking AdultsCompletedNCT02633839Phase 1
• A Study of the Safety and Pharmacokinetics of Levodopa Following Administration of CVT 301 (Levodopa Inhalation Powder) in Adults With AsthmaCompletedNCT02633007Phase 1
• Efficacy of Memantine add-on in the Treatment of Bipolar Disorder (Type I) Nonresponders or Partial Responders PatientsStatus unknownNCT02630888Phase 2
• Effects of Duloxetine on Pain Relief After Total Knee Arthroplasty in Central Sensitization PatientStatus unknownNCT02600247Not applicable
• The Use of Duloxetine for Cognition Improvement in Individuals With Mild Cognitive ImpairmentCompletedNCT02590874Phase 4
• Amantadine and Functional Improvement Following ABI Measured by MRI Tractography; A Pilot StudyStatus unknownNCT02566720Not applicable
• Psychological Intervention and Physiotherapy With Medication Improves CRPS Patients OutcomeCompletedNCT02467556Phase 4
• Treatment of Pendular Nystagmus in OPTCompletedNCT02466191Phase 4
• The Effect of Duloxetine on Mood, Quality of Life and Cognitive Functioning in Glioblastoma PatientsTerminatedNCT02443194Phase 3
• Target Hemodynamics and Brain Injury During General Anesthesia in the ElderlySuspendedNCT02428062Phase 2/3
• Pharmacovigilance in Gerontopsychiatric PatientsTerminatedNCT02374567Phase 3
• Prospective RCT on Post Prostatectomy Urine LeakStatus unknownNCT02367404Phase 3
• Effect of Preoperative Duloxetine on Quality of Recovery After Outpatient Laparoscopic SurgeryWithdrawnNCT02351440Phase 4
• L-dopa Versus Dopamine Agonists After Subthalamic Nucleus Deep Brain Stimulation in Parkinson's DiseaseStatus unknownNCT02347059Phase 2
• Combining Robotic-Assisted Therapy and Pharmacotherapy in Post-Stroke RehabilitationWithdrawnNCT02346630Phase 4
• Effect of Amantadine Administration on Spatial Functioning Following Traumatic Brain InjuryStatus unknownNCT02321761Phase 4
• Does Duloxetine Reduce Chronic Pain After Total Knee Arthroplasty?Status unknownNCT02307305Phase 2
• Bioavailability Study of Duloxetine Delayed-Release Capsules 60 mg Under Fasting ConditionCompletedNCT02291367Phase 1
• Bioavailability Study of Duloxetine Delayed-Relase Capsules 60 mg Under Fed ConditionCompletedNCT02291341Phase 1
• Prediction of Cognitive Properties of Memantine for Neurodegenerative DiseasesTerminatedNCT02288000Phase 1
• An Open-Label Trial of Memantine for Cognitive Impairment in Patients With Post-Traumatic Stress DisorderCompletedNCT02258828Phase 4
• The Effect of Norepinephrine and Dopamine on Radial Forearm Free Flap Tissue Oxygen Pressure and Microdialysate Metabolite MeasurementsCompletedNCT02241083Phase 4
• Effect of Memantine on ERP in Early Schizophrenia and Healthy SubjectsStatus unknownNCT02233556Not applicable
• Study to Evaluate the Efficacy of Duloxetine in Outpatients With Major Depressive Disorder and PainCompletedNCT02232555Phase 3
• Imaging Pain Relief in OsteoarthritisCompletedNCT02208778Phase 4
• A Phase 1, Drug Interaction Study Between AVP-786 and Paroxetine and Between AVP-786 and Duloxetine in Healthy SubjectsCompletedNCT02174822Phase 1
• Impact of Persistent Conductances on Motor Unit Firing in SCIStatus unknownNCT02136823Not applicable
• Study to Evaluate Safety and Efficacy of Dexpramipexole (KNS-760704) in Subjects With Hypereosinophilic SyndromeStatus unknownNCT02101138Phase 2
• Impact of Dopamine Infusion on Insulin Secretion in Healthy SubjectsCompletedNCT02053935Phase 1
• Pain Prevention and Treatment Through the Enhancement of the Anti-nociceptive Component of Pain Modulation ProfilesCompletedNCT02020122Not applicable
• Vasopressors for Cerebral OxygenationStatus unknownNCT02009007Phase 1
• A Study to Examine the, Safety, Tolerability and Pharmacokinetics Co-Administered Baclofen and Memantine in Obese and Lean, Otherwise Healthy AdultsCompletedNCT02001584Phase 1
• Memantine add-on for Cognitive and Negative Symptoms of SchizophreniaStatus unknownNCT02001103Phase 3

← Dopamine Agents overview